Evidence map›Paper›PMID 29138407›Full record

ArticleNPJ primary care respiratory medicine2017

Spirometry is not enough to diagnose COPD in epidemiological studies: a follow-up study.

Elena Andreeva, Marina Pokhaznikova, Anatoly Lebedev, Irina Moiseeva, Olga Kuznetsova, Jean-Marie Degryse

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02307799 (A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02307799 completednot on this map

A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology (RESPECT)

TypeobservationalSponsorUniversité Catholique de LouvainRan2012 to 2019Enrolled3,133ConditionsChronic Obstructive Pulmonary Disease
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fibrotic and emphysematous murine lung mechanics under negative-pressure ventilation.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Investigation of time profile of FEVScientific reports · 2023
    Article
  12. Article
  13. Lung proteomic biomarkers associated with chronic obstructive pulmonary disease.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Elena AndreevaInstitute of Health and Society, Université Catholique de Louvain, IRSS, Clos Chapelle-aux-Champs, 30/10.15, 1200, Brussels, Belgium.
Marina PokhaznikovaDepartment of Family Medicine, North-Western State Medical University named after I.I. Mechnikov, Kirochnaya str., 41, 191015, St. Petersburg, Russia.
Anatoly LebedevDepartment of Family Medicine, North-Western State Medical University named after I.I. Mechnikov, Kirochnaya str., 41, 191015, St. Petersburg, Russia.
Irina MoiseevaDepartment of Family Medicine, North-Western State Medical University named after I.I. Mechnikov, Kirochnaya str., 41, 191015, St. Petersburg, Russia.
Olga KuznetsovaDepartment of Family Medicine, North-Western State Medical University named after I.I. Mechnikov, Kirochnaya str., 41, 191015, St. Petersburg, Russia.
Jean-Marie DegryseInstitute of Health and Society, Université Catholique de Louvain, IRSS, Clos Chapelle-aux-Champs, 30/10.15, 1200, Brussels, Belgium. jean-marie.degryse@uclouvain.be.ORCID http://orcid.org/0000-0002-6813-1053
North-Western State Medical University named after I.I. Mechnikov · RUNorthern State Medical University · RUUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hallmark of the diagnosis of chronic obstructive pulmonary disease (COPD) is the measurement of post-bronchodilator (post-BD) airflow obstruction (AO) by spirometry, but spirometry is not enough for the provision of a clinical diagnosis. In the majority of previous epidemiological studies, COPD diagnosis has been based on spirometry and a few clinical characteristics. The aim of our study was to identify outcomes in patients newly diagnosed with airflow obstruction (AO) based on a diagnostic work-up conducted as part of a population-based cross-sectional study in North-Western Russia. Spirometry was performed before (pre-BD) and after BD administration, and AO was defined using the FEV1/FVC <0.70 and FEV1/FVC <lower limit of normal cut-off values. Relevant symptoms were recorded. Participants with AO identified at baseline were then examined by a pulmonologist, including a clinical examination and second spirometry with BD test. Of the 102 participants with post-BD AO in the initial assessment, only 60.8% still had AO identified at the second examination; among these patients, the following final diagnoses were reported: COPD (n = 41), asthma (n = 5), asthma-COPD overlap syndrome (ACOS) (n = 4) and likely ACOS (n = 5). Of the 65 participants with pre-BD AO, 23.1% had post-BD AO at the second assessment, and these patients had been diagnosed with COPD (n = 12), asthma (n = 1), ACOS (n = 1), likely ACOS (n = 1). Serial spirometric assessments complemented by a comprehensive clinical evaluation are recommended in new epidemiological studies.

Indexed as

SpirometryBronchodilator AgentsCross-Sectional StudiesFemaleFollow-Up StudiesForced Expiratory VolumeHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRussiaVital CapacityBronchodilator Agents

Identifiers

PMID29138407
PMCPMC5686137
OpenAlexW2767485250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.